Hypertriglyceridemia clinical trials at UCSD

1 in progress, 0 open to eligible people

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
San Diego, California and other locations

Last updated: November 26, 2025